EVOLVE
LIVE

Serial Number

90062393

Owner

Intellihealth, Inc.

Attorney

Jefferson F. Scher

First Use Date

Apr 24, 2020

Filing Date

Jul 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EVOLVE Trademark

Serial Number: 90062393 • Registration: 6631214

EVOLVE is a trademark filed by Intellihealth, Inc. on July 20, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Intellihealth, Inc. (4 trademarks)

600 California Street, 15th Floor
San Francisco, CA 94108

Entity Type: 03

Trademark Details

Filing Date

July 20, 2020

Registration Date

February 1, 2022

First Use Anywhere

April 24, 2020

First Use in Commerce

April 24, 2020

Published for Opposition

November 16, 2021

Goods & Services

Software as a service (SAAS) services featuring software for use by health care providers in implementing, managing, and monitoring pharmacotherapy and behavior modification programs for the prevention and treatment of obesity and obesity-linked diseases and conditions; Software as a service (SAAS) services featuring software for use by employers in implementing, managing, and monitoring employee benefit programs directed toward the prevention and treatment of obesity and obesity-linked diseases and conditions; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through identification, assessment and diagnosis of patients for the development of individual treatment plans, goals, and recommendations; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through collecting, logging, tracking, analyzing, managing, and reporting test results, activity data, and other health indications; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions providing clinical decision support and clinical outcome analytics; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through facilitation of provider-patient communications on goal setting, individual progress and plan adjustments; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions providing remote patient monitoring

Filing History

REGISTERED-PRINCIPAL REGISTER
Feb 1, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 16, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 27, 2021 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 14, 2021 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 10, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2021 CRFA
ASSIGNED TO LIE
Aug 31, 2021 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 26, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 26, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 26, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 26, 2021 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 26, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 26, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 26, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 4, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 6, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2020 NWOS
NEW APPLICATION ENTERED
Jul 23, 2020 NWAP